Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Bard Discontinues Tegress Incontinence Product Due To Postmarket Expense

Jan 01 2007

Related Content

Bard Pushes Back Expected Launch Date For AF Ablation Catheter

Apr 24 2006

Bard Buys Genyx For Urethral Bulking Agent Following FDA Sign-Off

Jan 17 2005

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
Editorial Standards
Award-Winning Journalism
AdvertiseOpens in new window
Contact Us
Evaluate Home

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Medtech Top 100 Ranking
Data Trackers
FDA Warning Letters

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window